MATINAS BIOPHARMA HLDGS INC - COM (MTNB) Institutional Ownership

CUSIP: 576810105

13F Institutional Holders and Ownership History from Q1 2015 to Q4 2024

Type / Class
Equity / COM
Symbol
MTNB on NYSE
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Investment Quick Answers

What is CUSIP 576810105?
CUSIP 576810105 identifies MTNB - MATINAS BIOPHARMA HLDGS INC - COM in SEC 13F datasets.

Where can I see the latest institutional holders?
Use the ownership history tables below to review the newest available institutional filing periods.

Institutional Holders of MATINAS BIOPHARMA HLDGS INC - COM (MTNB) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2024 Q4 0 $0 -$72,000 0
2024 Q3 775,000 $72,000 -$5,624,874 $0.09 1
2024 Q2 38,876,085 $6,153,838 +$1,908,950 $0.16 48
2024 Q1 25,448,437 $6,909,062 -$32,709 $0.27 41
2023 Q4 25,887,296 $5,603,625 +$75,046 $0.22 51
2023 Q3 25,944,206 $3,371,148 -$134,731 $0.13 47
2023 Q2 25,833,840 $9,301,533 -$279,636 $0.36 50
2023 Q1 26,534,089 $12,550,191 -$332,012 $0.47 50
2022 Q4 27,155,185 $13,575,184 -$264,022 $0.50 55
2022 Q3 27,870,177 $17,966,158 +$449,589 $0.64 49
2022 Q2 27,168,050 $21,476,641 +$1,558,684 $0.79 46
2022 Q1 25,191,288 $20,268,821 -$1,943,725 $0.80 51
2021 Q4 27,071,220 $27,339,139 +$1,012,208 $1.01 61
2021 Q3 25,746,480 $33,469,000 -$8,502,582 $1.30 66
2021 Q2 37,715,189 $29,223,858 -$4,042,320 $0.78 62
2021 Q1 39,726,412 $41,732,261 -$4,932,100 $1.05 78
2020 Q4 41,911,230 $57,013,842 -$4,621,904 $1.36 69
2020 Q3 45,435,751 $34,809,019 -$1,558,372 $0.77 59
2020 Q2 47,446,677 $36,681,019 -$4,533,437 $0.77 63
2020 Q1 53,407,804 $32,035,015 +$13,704,375 $0.60 62
2019 Q4 29,675,710 $67,359,057 +$10,094,775 $2.27 61
2019 Q3 26,293,621 $16,582,017 -$5,754,546 $0.63 35
2019 Q2 32,338,949 $27,700,017 -$5,280,255 $0.86 46
2019 Q1 37,707,146 $41,099,897 +$27,202,667 $1.09 52
2018 Q4 13,800,076 $8,236,214 +$3,552,167 $0.60 32
2018 Q3 7,173,853 $6,599,409 -$807,474 $0.92 30
2018 Q2 8,427,805 $3,658,048 -$1,849,798 $0.43 36
2018 Q1 10,993,080 $8,409,393 +$21,190 $0.77 43
2017 Q4 11,171,660 $12,956,282 -$321,058 $1.16 49
2017 Q3 11,404,031 $15,048,539 +$1,113,831 $1.32 46
2017 Q2 10,626,469 $17,956,106 +$13,446,817 $1.69 44
2017 Q1 2,513,017 $7,011,565 +$7,011,565 $2.77 19
2016 Q3 181,600 $291,000 -$3,205 $1.60 1
2016 Q2 183,600 $145,000 $0.79 1
2016 Q1 183,600 $130,000 -$54,758 $0.71 1
2015 Q4 243,400 $207,000 +$131,000 $0.85 2
2015 Q3 89,800 $74,000 +$49,443 $0.82 1
2015 Q2 29,800 $30,000 $1.01 1
2015 Q1 29,800 $16,000 +$16,000 $0.54 1